Charles River’s discovery-focused site in Leiden, the Netherlands has in-depth expertise in building disease-relevant cell-based models employing human (primary) cells or stem cell-derived cells to support the development of new therapies in different phases of the preclinical stage. Therapeutic modalities tested using these complex cellular assays include small
and large molecules, antibodies, antisense oligonucleotides (ASO), and cell and gene therapies.
Learn more about our Discovery services here: [ Ссылка ]
